Biontech bntx stock
WebBioNTech SE Sponsored ADR (BNTX) Stock Moves -0.68%: What You Should Know. Zacks. Feb-06-23 06:15AM. The 3 Most Undervalued Growth Stocks for Your February … WebIn depth view into BNTX (BioNTech) stock including the latest price, news, dividend history, earnings information and financials. BioNTech SE (BNTX) 126.95 -1.95 ( -1.51% ) USD …
Biontech bntx stock
Did you know?
WebApr 5, 2024 · BNTX / Overview BioNTech SE ADR U.S.: Nasdaq Add to Watchlist 0.00 BNTX Real Time Quote About BioNTech SE ADR BioNTech SE engages in the development of novel medicines at the intersection... WebApr 11, 2024 · See the latest BioNTech SE ADR stock price (NASDAQ:BNTX), related news, valuation, dividends and more to help you make your investing decisions.
WebMar 2, 2024 · Although shares of biotech company BioNTech ( BNTX -1.37%) have recently fallen along with most other stocks, the vaccine maker's performance over the past 12 months remains above that of the... WebBNTX Stock 12 Months Forecast. $173.70. (34.76% Upside) Based on 11 Wall Street analysts offering 12 month price targets for BioNTech SE in the last 3 months. The …
WebHome BNTX • NASDAQ BioNTech SE - ADR Follow Share $128.90 Apr 6, 8:00:00 PM GMT-4 · USD · NASDAQ · Disclaimer search Compare to Moderna Inc $158.27 MRNA2.37% Novavax Inc $8.46 NVAX11.46% Pfizer... WebFounded. 2008. BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, …
WebMar 27, 2024 · The outlook comes on the heels of a strong fourth-quarter report. BioNTech earned 9.26 euros a share on 4.28 billion euros in sales. That comes out to about $9.97 …
WebMar 2, 2024 · Biopharmaceutical New Technologies or BioNTech ( NASDAQ: BNTX) is a large ($31 billion market cap) immunotherapy company. They are developing cancer product candidates (Figure 1) but known mostly ... cynthia freeland picksWebApr 6, 2024 · A high-level overview of BioNTech SE (BNTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. cynthia freeman authorWebFintel reports that on April 10, 2024, JP Morgan maintained coverage of BioNTech SE (NASDAQ:BNTX) with a Neutral recommendation. Analyst Price Forecast Suggests 52.89% Upside As of April 7, 2024 ... billy the kid and hico texasWebBNTX Stock 12 Months Forecast $173.70 (34.76% Upside) Based on 11 Wall Street analysts offering 12 month price targets for BioNTech SE in the last 3 months. The average price target is $173.70 with a high forecast of $260.00 and a low forecast of $130.00. The average price target represents a 34.76% change from the last price of $128.90. billy the kid and jesse evansWebFounded. 2008. BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, … cynthia freeman-smallsWebApr 10, 2024 · 0. 0. In the last 3 months, 12 analysts have offered 12-month price targets for BioNTech. The company has an average price target of $169.33 with a high of $216.00 and a low of $128.00. Below is a ... billy the kid belt buckleWebBNTX Stock Summary. BNTX's current price/earnings ratio is 3.02, which is higher than merely 4.86% of US stocks with positive earnings. With a year-over-year growth in debt of -35.15%, BIONTECH SE's debt growth rate surpasses merely 8.03% of about US stocks. billy the kid and jesse